Dr. David J. D'Ambrosio, MD

Dr. D'Ambrosio practices at Community Medical Center in Toms River, New Jersey, part of RWJBarnabas Health.

Dr. D'Ambrosio's NPI, 1043485303, was assigned on April 28, 2008. Dr. D'Ambrosio graduated from Renaissance School of Medicine at Stony Brook University in 2003. Dr. D'Ambrosio holds New Jersey license 25MA08373600.

Dr. D'Ambrosio's primary practice is Community Medical Center, at 99 Rt 37 West, Toms River, NJ 08755 in Ocean County. The practice phone is (732) 557-8000.

Dr. D'Ambrosio's primary practice is Community Medical Center in Toms River, New Jersey, part of RWJBarnabas Health. Dr. D'Ambrosio is also affiliated with Ocean University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. D'Ambrosio to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. D'Ambrosio practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. D'Ambrosio's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. D'Ambrosio is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. D'Ambrosio's licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. D'Ambrosio treats.

CMS data shows 3,766 Medicare services from Dr. D'Ambrosio across 25 procedure codes in 2024, for 390 Medicare patients. Medicare paid $275,760 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 390 Medicare patients who saw Dr. D'Ambrosio in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. D'Ambrosio's median patient age at 77, with 47% women.

In 2024, Dr. D'Ambrosio wrote 170 Medicare Part D claims for 81 patients. 94% of them were for generic drugs. CMS names the drug for 99 of them, across 4 drugs with 11 or more claims each, at $1,166 in total drug cost. In 2023, CMS named 85 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. D'Ambrosio for performance year 2024, reported through an alternative payment model (APM). Dr. D'Ambrosio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. D'Ambrosio, published from 2007 to 2024. 2008 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Prostate-Specific Antigen and Radiotherapy, Conformal. Dr. D'Ambrosio has published most often in Int J Radiat Oncol Biol Phys. Dr. D'Ambrosio's most frequent co-authors are Mark K. Buyyounouski, MD, Eric Mark Horwitz, MD and Alan Pollack, MD.

Dmand AI links Dr. D'Ambrosio to 2 clinical trials. Conditions studied include Uterine Cervical Neoplasms and Uterine Cervical Diseases. GOG Foundation sponsors the most, 2.

CMS Open Payments shows 69 general payments to Dr. D'Ambrosio from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Myriad Genetic Laboratories, Inc. paid the most, $200.

Dr. D'Ambrosio graduated from Renaissance School of Medicine at Stony Brook University in 2003. Dr. D'Ambrosio is a member of ASTRO and ASCO.

Dr. D'Ambrosio is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.